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Indigenous Dengue 
Fever, Buenos 
Aires, Argentina
To the Editor: For 2 decades 
dengue has increased in the Americas, 
with epidemic peaks every 3 to 5 years 
(1). The disease has reemerged in 3 
South American countries bordering 
Argentina, namely, Bolivia, Brazil, 
and Paraguay. 
Argentina had remained free from 
dengue for >80 years before the dis-
ease was reintroduced in 1998 (2) as 
a consequence of insuffi cient mos-
quito control and importation of cases 
from disease-epidemic areas. Since 
then, indigenous dengue circulation 
has only been reported in the northern 
provinces of the country, which are 
close to endemoepidemic countries. 
However, the principal dengue vec-
tor, the Aedes aegypti mosquito,, has 
spread southward to latitude 35°S near 
Buenos Aires (3). 
We describe what might be the 
southernmost indigenous case of 
dengue fever documented in South 
America; this case occurred in 2007, 
an epidemic peak year for the disease 
on this continent (1). The patient was 
a pneumonologist who worked part-
time at Muñiz Hospital, a referral 
infectious diseases treatment center 
in the Buenos Aires Federal District. 
She also provided healthcare at an 
outpatient clinic in Lanus, her town of 
residence, a suburb 6 km south of the 
Federal District. Febrile illness started 
suddenly in February 2007, midsum-
mer season in Argentina. On day 5 of 
illness, fever was replaced by a short-
lived rash and itching followed by as-
thenia and nausea that persisted for 2 
days. The patient had not traveled or 
been accidentally exposed to patients’ 
blood during the previous weeks. She 
had never been vaccinated against yel-
low fever. Dengue fever was only sus-
pected retrospectively. 
Serologic results provided sup-
portive evidence of a recent dengue 
infection i.e., presence of immuno-
globulin M, as determined by anti-
body-capture enzyme immunoassay, 
and immunoglobulin G seroconversion 
by 90% plaque reduction neutraliza-
tion test on Vero cells (4). As shown in 
the Table, dengue virus serotype 3 was 
identifi ed, and antibody results were 
negative for 3 other fl aviviruses. Thus, 
this case fulfi ls Pan American Health 
Organization criteria for the diagnosis 
of dengue fever (5). Household con-
tacts were seronegative. 
For several years, conditions have 
been set for dengue virus circulation in 
Buenos Aires’ urban and suburban ar-
eas because of the abundance of mos-
quitoes and disease in persons recently 
returning from neighboring countries. 
Risk for vector transmission is highest 
in the peripheral quarters of the city 
and towards late summer (6). Besides, 
Buenos Aires, like other Latin Ameri-
can metropolitan areas, is undergoing 
demographic changes that convey fur-
ther risk for mosquito-borne disease 
transmission, namely, accelerated 
population growth mainly caused by 
informal settlements, defi cient public 
health infrastructure and basic ser-
vices, unregulated immigration from 
neighboring countries, and increased 
international mobility especially in or 
from neighboring countries (1). 
Only imported dengue cases have 
been previously documented in Bue-
nos Aires (2). According to offi cial in-
formation, all 158 cases confi rmed by 
antibody conversion in Buenos Aires 
Federal District and Province during 
2007 were also imported (7). Of these, 
50 occurred in the southern suburban 
district where our patient lives and 
works. In the summer of 2007, dengue 
infection was mainly introduced into 
the area by Paraguayan natives living 
in Buenos Aires who had recently vis-
ited their homeland. Dengue 3 serotype 
conversion was demonstrated in most 
of the cases investigated by plaque re-
duction neutralization assay, except for 
a few cases imported from Brazil, in 
which dengue 1 serotype was detected. 
The opinions expressed by authors con-
tributing to this journal do not necessar-
ily refl ect the opinions of the Centers for 
Disease Control and Prevention or the 
institutions with which the authors are af-
fi liated.
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Most of the patients whose cases 
were diagnosed in Buenos Aires, in-
cluding 5 who required hospitaliza-
tion, were referred to Muñiz Hospital. 
Built a century ago, Muñiz Hospital 
comprises a number of independent 
pavilions surrounded by a spacious 
garden, where mosquitoes thrive, 
especially in summer. Thus, vector-
borne infection in this case might have 
occurred either in Muñiz Hospital, in 
the Federal District, or in the southern 
city suburb, where the patient lives 
and works.
Until recently, dengue had not 
been suspected in patients with a fever 
living in the Buenos Aires area in the 
absence of a recent history of travel to 
an endemoepidemic area. Confi rma-
tion of our case was evidence of local 
circulation of dengue virus. Thereafter, 
serum testing became recommended in 
Buenos Aires for acute febrile illness, 
among other dengue surveillance in-
terventions in the area. More recently, 
epidemiologic surveillance of febrile 
illness has been strengthened country-
wide upon the recent reporting of yel-
low fever cases in Argentina (8).
No circulation of dengue virus 
was reported in Buenos Aires during 
the fi rst 10 epidemiologic weeks of 
2008. However, vector control mea-
sures should be strengthened to mini-
mize the risk of infective persons trig-
gering an epidemic of dengue or other 
fl avivirus disease.  
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Naegleria fowleri in 
Well Water
To the Editor: Naegleria fowleri, 
a protozoon found in hot springs and 
warm surface water, can cause pri-
mary amebic meningoencephalitis in 
humans. A survey of drinking water 
supply wells in Arizona determined 
that wells can be colonized and may 
be an unrecognized source of this or-
ganism that could present a human 
health risk.
N. fowleri is a free-living amebo-
fl agellate found in warm bodies of wa-
ter such as ponds, irrigation ditches, 
lakes, coastal waters, and hot springs 
and can cause primary amebic menin-
goencephalitis. Humans come into 
contact with N. fowleri by swimming 
or bathing, particularly in surface wa-
ters. The ameba enters the nasal pas-
sages, penetrates the nasopharyngeal 
mucosa, and migrates to the olfactory 
nerves, eventually invading the brain 
through the cribriform plate (1). From 
1995 to 2004, N. fowleri killed 23 per-
sons in the United States (2), includ-
Table. Serologic findings of an autochthonous case of dengue fever, Buenos Aires, February 2007 
Plaque reduction neutralization test (90%) 
Date (days after onset)
MAC-
ELISA*
Saint Louis 
encephalitis virus
West Nile 
virus 
Yellow fever 
virus
Dengue 1 
virus
Dengue 2 
virus
Dengue 3 
virus
Dengue 4 
virus 
2007 Jul 7 (16) + <20 <20 <20  80 <20  80 <20
2007 Apr 13 (53) ND <20 <20 <20  40 <20  640 <20
*Immunoglobulin M antibody-capture enzyme immunoassay with suckling mouse dengue virus antigen mixture of dengue 1, dengue 2, dengue 3, and 
dengue 4 serotypes. ND, not determined. 
